Skip to content

Functional Outcome in Operative and Nonoperative Management in Isolated Greater Tuberosity Fracture of Humerus Bone

Functional Outcome in Operative and Nonoperative Management in Isolated Greater Tuberosity Fracture of Humerus Bone: (cohort Study)

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06603428
Enrollment
66
Registered
2024-09-19
Start date
2024-10-10
Completion date
2026-10-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Greater Tuberosity Fracture

Brief summary

Constant score for functional outcome in operative and non-operative management in isolated greater tuberosity fractures of humerus bone.

Detailed description

Fractures of the greater tuberosity (GT) often occur with more complex proximal humerus fractures and are less frequently observed as an isolated pathology. Only 14-20% of proximal humerus fractures are isolated lesions of the GT. Up to 30% of these fractures are associated with anterior glenohumeral dislocations. According to Neer, a displacement of the fragment \>5mm and 30°, or \>3 mm of displacement in active patients involved in frequent overhead activity is believed to be an indication for operative treatment. However, indication for all other fractures had managed by nonoperative treatment is unclear. Currently, there is a lack of evidence in the literature to support either conservative or operative treatment strategies in GT humerus fractures. The fracture type and the etiology of the fracture impact the decision- making and the final outcome also remains unclear. age of more than 65 years as an important risk factor for secondary displacement in the conservative management of fractures of the greater tuberosity. Furthermore, fracture type and shoulder joint dislocations were factors associated with show increased relative risks for secondary fragment displacement.

Interventions

DEVICEinternal fixation by plate or screws

\- Patients more than 5 ml displacement of GT fracture (3ml in active highly demanded patient) are for internal fixation, others less this are for conservative management.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* 1-history of traumatic isolated GT fracture.

Exclusion criteria

\- 1- associated proximal humeral fracture. 2 - previous shoulder pathology.

Design outcomes

Primary

MeasureTime frameDescription
Constant score for functional outcomesfollow up 1 yearA-Pain (/15): Average(1+2) A 1. Do you have pain in your shoulder (normal activities)? No =15 pts,Mild pain =10 pts,Moderate =5 pts,Severe or permanent =0. 2. Linear scale: If 0 means no pain and 15 is the maximum pain you can experience, please circle where is the level of pain of your shoulder.(Points given are inverse to the scale.E.g. level 5 in the scale means 10 points) B- Activities of daily living (/20) Total (1 + 2) B 1. Is your occupation or daily living limited by your shoulder? No=4,Moderate limitation =2,Severe limitation=0 2. Are your leisure and recreational activities limited by your shoulder? No=4,Moderate limitation = 2,Severe limitation=0 C.- Range of movement (leave this for the doctor or physiotherapist) (/40):Total (1 + 2 ) C 1.- FWD Flexion: 0-30 0 pts 2-Abduction: 0-30 D.- Power (/25): Points: average (kg) x 2= D First pull:Second pull:Third pull:Fourth pull:Fifth pull: Average pulls: TOTA

Countries

Egypt

Contacts

Primary ContactKerolos Z Thabet, master
KerolosZaghloul@med.nvu.edu.eg01096271767
Backup Contacthesham A kady, prof
heshamelkady9919@gmail.com01005211797

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026